Intercell vaccine gets U.S. paediatric approval

VIENNA Tue May 21, 2013 2:42am EDT

VIENNA May 21 (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for paediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February.

"For the first time in nearly two years, a licensed vaccine will now be available to vaccinate traveling children and children of forward-deployed military personal in Asia as well against JE," Chief Executive Thomas Lingelbach said in a statement, calling the step a key growth element for the product.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.